Janssen

Pharmaceutical business founded at Beerse in Belgium in 1953 by the physician and chemist Paul Janssen, bought by Johnson & Johnson in 1961, which became the group's worldwide pharmaceutical arm and was renamed Johnson & Johnson Innovative Medicine in 2023. Discovers, develops, makes and sells prescription medicines in oncology, immunology, neuroscience, infectious diseases and vaccines, pulmonary hypertension and cardiovascular and metabolic disease, and runs its own research campuses, manufacturing plants and preclinical and clinical development laboratories.